NDTV-Dettol Banega Swasth Swachh India NDTV-Dettol Banega Swasth Swachh India
  • Home/
  • News/
  • Antibodies Against SARS-Cov-2 Remain Stable, Even Increase Seven Months After Infection: Study

News

Antibodies Against SARS-Cov-2 Remain Stable, Even Increase Seven Months After Infection: Study

We saw an increase of IgG anti-spike antibodies in 75 per cent of the participants from month five onwards, without any evidence of re-exposure to the novel coronavirus, said Gemma Moncunill, senior co-author of the study

Antibodies Against SARS-Cov-2 Remain Stable, Even Increase Seven Months After Infection: Study
Highlights
  • The research team analysed blood samples from 578 participants
  • Blood samples were taken at 4 different times between March-October 2020
  • Levels of antibodies against different SARS-CoV-2 antigens were evaluated

Barcelona: According to a recent study in a cohort of healthcare workers, the levels of IgG antibodies against SARS-CoV- 2 Spike protein remained stable, or even increased, seven months after the infection. The results, published in the journal ‘Nature Communications’, also supported the idea that pre-existing antibodies against common cold coronaviruses could protect against COVID-19. The study was coordinated by the Barcelona Institute for Global Health (ISGlobal), an institution supported by the “la Caixa” Foundation, in collaboration with the Hospital Clinic of Barcelona.

Also Read: Double Vaccinated Individuals 3 Times Less Likely To Get COVID-19: UK Study

In order to predict the pandemic’s evolution and develop effective strategies, it is critical to better understand the dynamics and duration of immunity to SARS-CoV-2 as well as the possible role of pre-existing antibodies against the coronaviruses that cause common colds. With this goal in mind, the team led by ISGlobal researcher Carlota Dobano followed a cohort of healthcare workers at the Hospital Clinic (SEROCOV study) from the beginning of the pandemic, in order to evaluate the levels of antibodies against different SARS-CoV-2 antigens over time.

This is the first study that evaluates antibodies to such a large panel of SARS-CoV-2 antibodies over 7 months, said Researcher Dobano.

Also Read: Centre To Examine Sewage Samples To Ascertain Coronavirus Circulation Intensity: Report

The research team analysed blood samples from 578 participants, taken at four different time points between March and October 2020. They used the Luminex technology to measure, in the same sample, the level and type of IgA, IgM or IgG antibodies to 6 different SARS-CoV-2 antigens as well as the presence of antibodies against the four coronaviruses that cause common colds in humans. They also analysed the neutralising activity of antibodies in collaboration with researchers at the University of Barcelona.

The study had funding from the European innovation network EIT Health. The findings showed that the majority of infections among healthcare workers occurred during the first pandemic wave (the percentage of participants with SARS-CoV-2 antibodies increased only slightly between March and October — from 13.5 per cent to 16.4 per cent). With the exception of IgM and IgG antibodies against the nucleocapsid (N), the rest of IgG antibodies (including those with neutralising activity) remained stable over time, confirming results from other recent studies.

Also Read: WHO Calls For ‘Moratorium’ On COVID-19 Vaccine Boosters Until At Least September-End To Address Vaccination Disparity

Rather surprisingly, we even saw an increase of IgG anti-Spike antibodies in 75 per cent of the participants from month five onwards, without any evidence of re-exposure to the virus, said Gemma Moncunill, senior co-author of the study.

No reinfections were observed in the cohort. Regarding antibodies against human cold coronaviruses (HCoV), the results suggest that they could confer cross-protection against COVID-19 infection or disease. People who were infected by SARS-CoV-2 had lower levels of HCoV antibodies. Moreover, asymptomatic individuals had higher levels of anti-HCoV IgG and IgA than those with symptomatic infections.

Although cross-protection by pre-existing immunity to common cold coronaviruses remains to be confirmed, this could help explain the big differences in susceptibility to the disease within the population, concluded Researcher Dobano.

Also Read: Long-Lasting Covid Symptoms Rare In Children: Lancet Study

(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)

NDTV – Dettol Banega Swasth India campaign is an extension of the five-year-old Banega Swachh India initiative helmed by Campaign Ambassador Amitabh Bachchan. It aims to spread awareness about critical health issues facing the country. In wake of the current COVID-19 pandemic, the need for WASH (WaterSanitation and Hygiene) is reaffirmed as handwashing is one of the ways to prevent Coronavirus infection and other diseases. The campaign highlights the importance of nutrition and healthcare for women and children to prevent maternal and child mortality, fight malnutrition, stunting, wasting, anaemia and disease prevention through vaccines. Importance of programmes like Public Distribution System (PDS), Mid-day Meal Scheme, POSHAN Abhiyan and the role of Aganwadis and ASHA workers are also covered. Only a Swachh or clean India where toilets are used and open defecation free (ODF) status achieved as part of the Swachh Bharat Abhiyan launched by Prime Minister Narendra Modi in 2014, can eradicate diseases like diahorrea and become a Swasth or healthy India. The campaign will continue to cover issues like air pollutionwaste managementplastic banmanual scavenging and sanitation workers and menstrual hygiene

[corona_data_new]
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This website follows the DNPA Code of Ethics

© Copyright NDTV Convergence Limited 2024. All rights reserved.